We are live on ! Find out more
FPF

FNY Partners Fund Portfolio holdings

AUM $185M
1-Year Est. Return 32.58%
This Fund
S&P 500
This Quarter Est. Return
+14.16%
1 Year Est. Return
+32.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$588M
AUM Growth
+$175M
Cap. Flow
+$118M
Cap. Flow %
20.16%
Top 10 Hldgs %
54.34%
Holding
835
New
294
Increased
101
Reduced
91
Closed
281

Sector Composition

Rank Sector Weight
1 Healthcare 26.11%
2 Technology 14.68%
3 Communication Services 11.2%
4 Financials 9.54%
5 Consumer Staples 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBUS icon
326
Cibus
CBUS
$126M
$24K ﹤0.01%
+20
New +$17K
GYRE icon
327
Gyre Therapeutics
GYRE
$699M
$23K ﹤0.01%
+623
New +$18.7K
PRTK
328
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$23K ﹤0.01%
+945
New +$22K
GIS icon
329
PUT
General Mills
GIS
$22.2B
$22K ﹤0.01%
435
-160
-27% -$8.77K
CPE
330
DELISTED
Callon Petroleum Company
CPE
$22K ﹤0.01%
+200
New +$21.3K
XLK icon
331
State Street Technology Select Sector SPDR ETF
XLK
$121B
$21K ﹤0.01%
744
+260
+54% +$7.49K
XLV icon
332
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$21K ﹤0.01%
+269
New +$21.6K
ETFC
333
DELISTED
E*Trade Financial Corporation
ETFC
$21K ﹤0.01%
500
-1,750
-78% -$71.1K
PF
334
CALL
DELISTED
Pinnacle Foods, Inc.
PF
$21K ﹤0.01%
400
-138
-26% -$8.19K
LVLT
335
DELISTED
Level 3 Communications Inc
LVLT
$21K ﹤0.01%
400
-800
-67% -$44.6K
BCRX icon
336
BioCryst Pharmaceuticals
BCRX
$2.51B
$20K ﹤0.01%
4,000
GOOS
337
Canada Goose Holdings
GOOS
$805M
$20K ﹤0.01%
+1,000
New +$19K
PI icon
338
Impinj
PI
$5.2B
$20K ﹤0.01%
+500
New +$21K
STRR
339
DELISTED
Star Equity Holdings
STRR
$20K ﹤0.01%
120
RAD
340
DELISTED
Rite Aid Corporation
RAD
$20K ﹤0.01%
535
-3,250
-86% -$154K
STS
341
CALL
DELISTED
Supreme Industries Inc Class A
STS
$20K ﹤0.01%
+4
New +$75
JD icon
342
CALL
JD.com
JD
$38.8B
$19K ﹤0.01%
+522
New +$22.3K
PRKS icon
343
United Parks & Resorts
PRKS
$1.93B
$19K ﹤0.01%
+1,500
New +$20.5K
UBP
344
DELISTED
Urstadt Biddle Properties Inc.
UBP
$19K ﹤0.01%
1,100
+400
+57% +$6.97K
AUPH icon
345
Aurinia Pharmaceuticals
AUPH
$2.17B
$18K ﹤0.01%
3,000
XOM icon
346
ExxonMobil
XOM
$644B
$18K ﹤0.01%
220
-5,871
-96% -$466K
ANAB icon
347
AnaptysBio
ANAB
$1.67B
$17K ﹤0.01%
+500
New +$13.5K
NBR icon
348
Nabors Industries
NBR
$1.39B
$17K ﹤0.01%
42
+40
+2,000% +$14.6K
O icon
349
Realty Income
O
$58.6B
$17K ﹤0.01%
+310
New +$17.2K
RILYZ
350
DELISTED
B. Riley Financial, Inc. 7.50% Senior Notes Due 2027
RILYZ
$17K ﹤0.01%
700

Similar funds

FNY Partners Fund's Q3 2017 Portfolio in Review

As of Q3 2017, FNY Partners Fund held 835 positions worth $588M, up 42% from $413M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

FNY Partners Fund deployed $118M of net new capital in Q3 2017, opening 294 new positions and adding to 101 existing holdings. Its largest new stake was Kite Pharma, Inc.: 379,510 shares worth $68.2M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 10% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Altaba Inc, an estimated $24.9M trimmed.

  • FNY Partners Fund's largest Q3 2017 buy was Kite Pharma, Inc.: 379,510 shares worth $68.2M.
  • FNY Partners Fund added most to Time Warner Inc in Q3 2017, an estimated $36.4M increase.
  • FNY Partners Fund's biggest Q3 2017 reduction was Altaba Inc, cutting an estimated $24.9M.
  • FNY Partners Fund fully exited Allied World Assurance Co Hld Lt in Q3 2017, selling an estimated $54.6M.
  • FNY Partners Fund's ten largest holdings make up 54% of its $588M portfolio in Q3 2017.
  • FNY Partners Fund opened 294 new positions and closed 281 in Q3 2017.
  • FNY Partners Fund's portfolio value rose 42% quarter-over-quarter to $588M.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.